[1]
Sarma, I.D. et al. 2025. Aprepitant versus Olanzapine in Patients of Breast Cancer on Adriamycin and Cyclophosphamide Regimen – Role in Effectiveness of Prevention of Nausea and Vomiting. Acta medica Lituanica. 32, 1 (Jun. 2025), 220–227. DOI:https://doi.org/10.15388/Amed.2025.32.1.22.